Oxford, England, United Kingdom
Neurvati is a Blackstone Life Sciences portfolio company established to advance development of high-potential technologies to address a broad range of unmet needs in the treatment of neurological and psychiatric disorders.
Grinspan Lab: Under rat cuprizone model of demyelination, working to determine the role of copper ions in mature oligodendrocyte function, focusing on the lysosomal cation TRPML1 channel. Research awarded 2025 CHOP Scientific Symposium Prize.
NRSC 2110/BIOL 2110 — Molecular and Cellular Neurobiology (Fall 2024)
Performed data analytics for DMT discontinuation studies tracking relapse rate and MRI progressions. Shadowed weekly in the center's MS clinic.
Shindler/Ross Lab: Studied mitochondrial turnover and SIRT1 vector gene-therapy intervention for retinal neurodegeneration in a traumatic optic neuropathy mouse model.